Dr. Mirit Lotan, a founding partner at CDS-LUTHI Intellectual Property Group, holds a Ph.D. in Biology from The Weizmann Institute of Science. Her journey, spanning over 26 years in intellectual property, includes a decade in the biotech industry where she integrated her expertise as a patent attorney with licensing and business development, eventually leading to a shift in focus to serving a diverse clientele in the field. Mirit’s vast expertise encompasses patent drafting and prosecution, patentability and freedom-to-operate (FTO) analyses, and strategic consultation on IP matters across various fields from basic to applied science, including molecular biology, drug development, diagnostics, therapeutic antibodies, and vaccines.
Her clientele includes multi-national corporations, academia and research institutes, as well as start-ups, showcasing her versatility in handling a diverse range of IP matters catering to different business needs. Beyond her work as a patent attorney, Mirit has also been a vocal contributor to public dialogues on critical issues, as evidenced by her podcast appearance in Calcalist, where she discussed the global implications of patent registration on COVID-19 vaccines.
Mirit’s dedication and natural flair for patent work have earned her recognition as a Recommended Lawyer in The Legal 500, 2023 edition, and a recommended individual in the prosecution category of IAM Patent 1000 2023. IAM commends her meticulous attention to detail and ability to work seamlessly with businesses to prepare robust claims and consider potential future applications and ranges of applicability.